Forum: Articles of Interest
07-31-2021, 06:02 PM
|
Replies: 0
Views: 1,563
SYD985 /trastuzumab duocarmazine
Hopefully another weapon to fight soon.
Positive Topline Survival Data Observed in Phase 3 Trial of SYD985 for HER2-Positive Metastatic Breast Cancer
...
|